Prior to the administration of the 64Cu-PCB-hnRNP, the tumor was blocked by injecting excess hnRNPA2B1 mAb (19.2-fold) and at 4 h p.i. organs were harvested for the biodistribution studies. This evidence concerns the gene HNRNPA2B1 and neoplasm.